Safety of Immediate Weight-Bearing as Tolerated After Well-Reduced Geriatric Hip

December 28, 2023 updated by: Far Eastern Memorial Hospital

Safety of Immediate Weight-Bearing as Tolerated After Well-Reduced Geriatric Hip Fracture

Purpose: Proximal femur fracture is a major traumatic injury in elderly populations; however, practical postoperative weight-bearing protocols are lacking. Therefore, the purpose of the present study was to investigate whether early weight-bearing status after proximal femur nail fixation is associated with any loss of reduction and evaluate the clinical outcomes of this intervention.

Patients and methods:

For this prospective single center clinical trial study, we recruited 14 proximal femur fracture cases, classified by AO/OTA 2018, receiving intramedullary nail fixation. Clinical outcomes included the Harris functional hip score and VAS pain score. Additionally, demographic data, radiological parameters, time to weight-bearing, mortality rate, medical and surgical complications, and final ambulation status were recorded.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • New Taipei City, Taiwan, 220
        • Far-Eastern Memorial Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patients with AO/OTA type 31 fractures were included, and all fractures were classified using intraoperative fluoroscopy with traction on the fracture table.

Exclusion Criteria:

  • Patients with pathological fractures, neurovascular insufficiency, ipsilateral lower extremity musculoskeletal injury, multiple fractures, or high risk of falling, including frequent falling accidents within 6 months, unsteady gait, ipsilateral neuropathy, limb weakness, and urinary incontinence were excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early-Weight bearing
Early Weight bearing was defined as starting Weight bearing within 48 h postoperatively, and WBAT referred to the adjustment of fracture site weight-bearing by pain tolerance.
The patients began early weight bearing under attending physician and physiotherapist surveillance within 48 hours after surgery. Patients were instructed to stand up near the bed, and muscle power, gait stability, and pain tolerance were recorded. The physiotherapist instructed the patients to perform early mobilization and weight bearing as tolerable by self-adjustment of body weight distribution over the bilateral lower extremities, and walking assistance was used to prevent repeat falling accidents.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Harris Hip Functional score
Time Frame: Functional and radiographic evaluations was performed at months 1 postoperatively
The questionaire to patient. (HHS score 0-100,<60 poor,>80 good)
Functional and radiographic evaluations was performed at months 1 postoperatively
Harris Hip Functional score
Time Frame: Functional and radiographic evaluations was performed at months 3 postoperatively
The questionaire to patient(HHS score 0-100,<60 poor,>80 good)
Functional and radiographic evaluations was performed at months 3 postoperatively
Harris Hip Functional score
Time Frame: Functional and radiographic evaluations was performed at months 6 postoperatively
The questionaire to patient(HHS score 0-100,<60 poor,>80 good)
Functional and radiographic evaluations was performed at months 6 postoperatively
Harris Hip Functional score
Time Frame: Functional and radiographic evaluations was performed at months 12 postoperatively
The questionaire to patient(HHS score 0-100,<60 poor,>80 good)
Functional and radiographic evaluations was performed at months 12 postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visual analog pain score
Time Frame: Record at months 1 postoperatively
Independent assessor (VAS:0-10)
Record at months 1 postoperatively
visual analog pain score
Time Frame: Record at months 3 postoperatively
Independent assessor(VAS:0-10)
Record at months 3 postoperatively
visual analog pain score
Time Frame: Record at months 6 postoperatively
Independent assessor(VAS:0-10)
Record at months 6 postoperatively
visual analog pain score
Time Frame: Record at months 12 postoperatively
Independent assessor(VAS:0-10)
Record at months 12 postoperatively
Complication
Time Frame: Functional and radiographic evaluations were performed at months 1, 3, 6, and 12 postoperatively
Loss of reduction, malunion or nonunion
Functional and radiographic evaluations were performed at months 1, 3, 6, and 12 postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

May 5, 2023

Study Registration Dates

First Submitted

July 7, 2023

First Submitted That Met QC Criteria

December 28, 2023

First Posted (Actual)

January 10, 2024

Study Record Updates

Last Update Posted (Actual)

January 10, 2024

Last Update Submitted That Met QC Criteria

December 28, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 109046-E

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bony Weight Bearing Disorder

Clinical Trials on Early-Weight bearing

3
Subscribe